Will new drugs change the standard of care for patients with mantle cell lymphoma
作者： Donald S. Colbourn , Jennifer E. Amengual , Changchun Deng , Ahmed Sawas , Owen A. O’Connor
DOI: 10.1586/14737140.2016.1127761
关键词:
摘要: Mantle Cell lymphoma is a heterogeneous malignancy that has different subtypes with variable levels of aggressiveness. Research on the pathobiology this disease helping us understand etiology for heterogeneity and potential to guide future therapeutic options. The availability Ki67 proliferation index use MIPI score can help determine which numerous options might be utilized. Minimal Residual Disease testing act as benefit maintenance therapy. This article discusses current standard care our understanding leading strategies improve patient outcomes some newer targeted agents.
sci-hub.se 参考文章(67)
Iida S, Namba M, Yamamoto K, Seto M, Ohtsuki T, Yawata Y, Akao Y, Miyoshi I, Utsumi Kr, Kubonishi I, Gene rearrangement and overexpression of PRAD1 in lymphoid malignancy with t(11;14)(q13;q32) translocation. Oncogene. ,vol. 7, pp. 1401- 1406 ,(1992)
N.S Andersen, M.K Jensen, P de Nully Brown, C.H Geisler, A Danish population-based analysis of 105 mantle cell lymphoma patients: incidences, clinical features, response, survival and prognostic factors European Journal of Cancer. ,vol. 38, pp. 401- 408 ,(2002) , 10.1016/S0959-8049(01)00366-5
Magda Pinyol, Luis Hernandez, Maite Cazorla, Milagros Balbı́n, Pedro Jares, Pedro L. Fernandez, Emilio Montserrat, Antonio Cardesa, Carlos Lopez-Otı́n, Elı́as Campo, Deletions and Loss of Expression of P16INK4a and P21Waf1 Genes Are Associated With Aggressive Variants of Mantle Cell Lymphomas Blood. ,vol. 89, pp. 272- 280 ,(1997) , 10.1182/BLOOD.V89.1.272
Tadeusz Robak, Huiqiang Huang, Jie Jin, Jun Zhu, Ting Liu, Olga S Samoilova, Halyna Pylypenko, Gregor Verhoef, Noppadol Siritanaratkul, Evgenii A Osmanov, Julia Alexeeva, Juliana Pereira, Jiri Mayer, Xiaonan Hong, Yoshiharu Maeda, Lixia Pei, Brendan Rooney, Helgi van de Velde, Franco Cavalli, Bortezomib (Btz) Dose Intensity Is the Strongest Predictor for Overall Survival (OS) in Mantle Cell Lymphoma (MCL) Patients (Pts) Not Considered for Transplantation, Receiving Frontline Btz Plus Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (VR-CAP) Therapy in the Phase 3 LYM-3002 Study Blood. ,vol. 124, pp. 4412- 4412 ,(2014) , 10.1182/BLOOD.V124.21.4412.4412
RI Fisher, S Dahlberg, BN Nathwani, PM Banks, TP Miller, TM Grogan, A clinical analysis of two indolent lymphoma entities: mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B-cell subcategories): a Southwest Oncology Group study Blood. ,vol. 85, pp. 1075- 1082 ,(1995) , 10.1182/BLOOD.V85.4.1075.BLOODJOURNAL8541075
Marie-Hélène Delfau-Larue, Wolfram Klapper, Françoise Berger, Fabrice Jardin, Josette Briere, Gilles Salles, Olivier Casasnovas, Pierre Feugier, Corinne Haioun, Vincent Ribrag, Catherine Thieblemont, Michael Unterhalt, Martin Dreyling, Elizabeth Macintyre, Christiane Pott, Olivier Hermine, Eva Hoster, High-dose cytarabine does not overcome the adverse prognostic value of CDKN2A and TP53 deletions in mantle cell lymphoma. Blood. ,vol. 126, pp. 604- 611 ,(2015) , 10.1182/BLOOD-2015-02-628792
R Rimokh, F Berger, G Delsol, I Digonnet, JP Rouault, JD Tigaud, M Gadoux, B Coiffier, PA Bryon, JP Magaud, Detection of the chromosomal translocation t(11;14) by polymerase chain reaction in mantle cell lymphomas. Blood. ,vol. 83, pp. 1871- 1875 ,(1994) , 10.1182/BLOOD.V83.7.1871.1871
Francesco Merli, Stefano Luminari, Fiorella Ilariucci, Mario Petrini, Carlo Visco, Achille Ambrosetti, Caterina Stelitano, Francesco Caracciolo, Nicola Di Renzo, Francesco Angrilli, Angelo M Carella, Isabella Capodanno, Elisa Barbolini, Sara Galimberti, Massimo Federico, None, Rituximab plus HyperCVAD alternating with high dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma, a multicentre trial from Gruppo Italiano Studio Linfomi. British Journal of Haematology. ,vol. 156, pp. 346- 353 ,(2012) , 10.1111/J.1365-2141.2011.08958.X
Elias Campo, N Lee Harris, Elaine S Jaffe, Stefano A Pileri, Harald Stein, Jurgen Thiele, James W Vardiman, None, WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues ,(2017)
Patrocinio Algara, Jose A. Martínez-Climent, Javier Menárguez, Elena Ruíz-Ballesteros, Fernando Solano, Antonia Rodríguez, Ana Dopazo, Manuela Mollejo, Javier García-Conde, Miguel A. Piris, Francisca I. Camacho, Paloma Martín, Nerea Martínez, The Molecular Signature of Mantle Cell Lymphoma Reveals Multiple Signals Favoring Cell Survival Cancer Research. ,vol. 63, pp. 8226- 8232 ,(2003)